Cargando…

Approach to the Patient With Treatment-resistant Acromegaly

Although most tumors in patients with acromegaly are benign and are cured or controlled by surgery and/or first-generation somatostatin receptor ligands therapy, some can behave more aggressively and are resistant to these standard therapies. Acromegaly, if left untreated, is a rare and chronic diso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coopmans, Eva C, van der Lely, Aart J, Neggers, Sebastian J C M M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Approach to the Patient
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315163/ https://www.ncbi.nlm.nih.gov/pubmed/35090028 http://dx.doi.org/10.1210/clinem/dgac037

Ejemplares similares

The position of combined medical treatment in acromegaly
por: Coopmans, Eva C., et al.
Publicado: (2019)

Approach to Diagnosing a Pediatric Patient With Severe Insulin Resistance in Low- or Middle-income Countries
por: van Heerwaarde, Alise A, et al.
Publicado: (2021)

Pregnancy and acromegaly
por: Muhammad, Ammar, et al.
Publicado: (2016)

Pegvisomant for acromegaly: does it always works?
por: Neggers, Sebastian J., et al.
Publicado: (2019)

Approach to the Patient: Diagnosis of Cushing Syndrome
por: Savas, Mesut, et al.
Publicado: (2022)

Approach to the Patient With Prolactinoma
por: Auriemma, Renata S, et al.
Publicado: (2023)

Approach to the Patient: Pharmacological Management of Trans and Gender-Diverse Adolescents
por: O’Connell, Michele A, et al.
Publicado: (2021)

Approach to the Patient: Management of Parathyroid Diseases Across Pregnancy
por: Appelman-Dijkstra, Natasha M, et al.
Publicado: (2022)

Approach to the Patient With Bone Fracture: Making the First Fracture the Last
por: Wang, Mawson, et al.
Publicado: (2023)

Approach to the Patient With Adrenal Hemorrhage
por: Elhassan, Yasir S, et al.
Publicado: (2022)

Approach to the Patient: “Utility of the Copeptin Assay”
por: Christ-Crain, Mirjam, et al.
Publicado: (2022)

Approach to the Patient With Prader–Willi Syndrome
por: Höybye, Charlotte, et al.
Publicado: (2022)

Approach to the Virilizing Girl at Puberty
por: Santi, Maristella, et al.
Publicado: (2020)

Approach to the Patient: Management of Pituitary Hormone Replacement Through Transition
por: Cerbone, Manuela, et al.
Publicado: (2022)

Approach to Hypophosphatemic Rickets
por: Ackah, Sarah A, et al.
Publicado: (2022)

Soluble Klotho: a possible predictor of quality of life in acromegaly patients
por: Coopmans, Eva C., et al.
Publicado: (2020)

Approach to the Patient: The Evaluation and Management of Men ≥50 Years With Low Serum Testosterone Concentration
por: Grossmann, Mathis, et al.
Publicado: (2023)

Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman
por: Hirschberg, Angelica Lindén
Publicado: (2022)

Approach to Interpreting Common Laboratory Pathology Tests in Transgender Individuals
por: Cheung, Ada S, et al.
Publicado: (2020)

Nonsurgical Management of Thyroid Nodules: The Role of Ablative Therapies
por: Stan, Marius N, et al.
Publicado: (2021)

Critical Illness–induced Corticosteroid Insufficiency: What It Is Not and What It Could Be
por: Téblick, Arno, et al.
Publicado: (2022)

Disorders of Salt and Water Balance After Pituitary Surgery
por: Brooks, Emily K, et al.
Publicado: (2022)

Combined treatment of somatostatin analogues with pegvisomant in acromegaly
por: Franck, S. E., et al.
Publicado: (2015)

Towards an Earlier Diagnosis of Acromegaly and Gigantism
por: Sisco, Jill, et al.
Publicado: (2021)

ACRODAT® and AcroVoice: an insight into a holistic approach to the management of acromegaly
por: Lundie, Mark, et al.
Publicado: (2019)

SAT-LB076 T2-Signal Intensity, SST Receptor Expression and First-Generation Somatostatin Analogues Efficacy Predict Hormone and Tumor Responses to Pasireotide in Acromegaly
por: Coopmans, Eva, et al.
Publicado: (2019)

Hypertension in Acromegaly in Relationship to Biochemical Control and Mortality: Global ACROSTUDY Outcomes
por: Vila, Greisa, et al.
Publicado: (2020)

Conversion of daily pegvisomant to weekly pegvisomant combined with long-acting somatostatin analogs, in controlled acromegaly patients
por: Neggers, Sebastian J. C. M. M., et al.
Publicado: (2011)

Predictors for Remission after Transsphenoidal Surgery in Acromegaly: A Dutch Multicenter Study
por: Coopmans, Eva C, et al.
Publicado: (2021)

Diagnostic and therapeutic approach to pulmonary infiltrates in cancer patients receiving immune checkpoint inhibitors
por: Fernández-Ruiz, Mario
Publicado: (2022)

Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study
por: Neggers, Sebastian JCMM, et al.
Publicado: (2015)

In active acromegaly, IGF1 bioactivity is related to soluble Klotho levels and quality of life
por: Varewijck, A J, et al.
Publicado: (2014)

Current management of CMV infection in cancer patients (solid tumors). Epidemiology and therapeutic strategies
por: García-Bustos, Víctor, et al.
Publicado: (2022)

Photodynamic Therapy for Chorioretinal Diseases: A Practical Approach
por: van Dijk, Elon H. C., et al.
Publicado: (2020)

COVID-19 in donation and transplant
por: Candel, Francisco Javier, et al.
Publicado: (2022)

Endocrine Disorders Are Prominent Clinical Features in Patients With Primary Antibody Deficiencies
por: Coopmans, Eva C., et al.
Publicado: (2019)

Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy
por: Brue, Thierry, et al.
Publicado: (2018)

Norovirus infection as a model of chronic or recurrent infection in common variable immunodeficiency
por: Moral, Pedro Moral, et al.
Publicado: (2022)

Risk factors and management of pasireotide-associated hyperglycemia in acromegaly
por: Gadelha, Mônica R, et al.
Publicado: (2020)

Unacylated ghrelin modulates circulating angiogenic cell number in insulin-resistant states
por: Özcan, Behiye, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_asktjn98job3tvliemovn7v9di